Cholesterol synthesis is regulated through feedback inhibition and transcription levels of HMG CoA reductase, the rate-limiting enzyme. Insulin increases and glucagon decreases HMG CoA reductase activity by dephosphorylation and phosphorylation respectively. Cholesterol is eliminated from the body through bile acids, bile salts, and coprostanol formed by gut bacteria. Clinical conditions related to cholesterol include atherosclerosis from excess levels, familial hypercholesterolemia due to defective LDL receptors, and familial HDL deficiency caused by a mutation preventing HDL cholesterol removal.